Topline Score

Topline score feature will be out soon.

Bio

Generated by
Topline AI

5.0

/5.0
/ Based on 1 ratings
  • (1)
  • (0)
  • (0)
  • (0)
  • (0)

Filter reviews by:

Fred Feldman

Anne worked for me at CPEX LLC when I was a Chief Science Officer there. She was one of my best hires there. She's an excellent biochemist and highly skilled in analytical chemistry with excellent skills immunochemistry. Anne is the kind of person who never takes anything for granted, is constantly looking for solutions, and is never satisfied until she knows she's found the right answer. Besides the excellent job she does in her specialties, she also mentors others around her and is an excellent example motivating other scientists in the laboratory..

You need to have a working account to view this content.
You need to have a working account to view this content.

Experience

    • United States
    • Biotechnology Research
    • 1 - 100 Employee
    • Technical Support Scientist
      • 2018 - Present
    • Biotechnology Research
    • 1 - 100 Employee
    • Consulting Scientist
      • 2015 - 2018

      Analytical review of Methods, Clinical and Preclinical data to support business development. Analytical review of Methods, Clinical and Preclinical data to support business development.

    • Pharmaceutical Manufacturing
    • 1 - 100 Employee
    • Director of QA/QC
      • 2012 - 2015

      Transfer and Validation of Analytical Methods from pharma clients to MRL testing laboratories. Review of SOP, stability and release documents for CRO. Transfer and Validation of Analytical Methods from pharma clients to MRL testing laboratories. Review of SOP, stability and release documents for CRO.

    • Principal Scientist
      • 2008 - 2011

      Developed analytical methods for Preclinical & Product Development. Investigation of peptides & proteins as potential drugs & vaccines, for nasal and intradermal delivery, using a proprietary permeation enhancer CPE-215. Regulatory support for CMC sections on nasal insulin, Nasulin. Technical transfer to CROs, audit of preclinical testing facilities. Developed analytical methods for Preclinical & Product Development. Investigation of peptides & proteins as potential drugs & vaccines, for nasal and intradermal delivery, using a proprietary permeation enhancer CPE-215. Regulatory support for CMC sections on nasal insulin, Nasulin. Technical transfer to CROs, audit of preclinical testing facilities.

    • Associate Director for QC Diagnostic Products & Reagents
      • 1995 - 2000

      Responsible for 21 lab personnel in two groups: Diagnostic Kits & Enzyme Reagents. Validation, Stability and Technical Support for cytokine ELISA kits. Method transfer and support for Manufacturing. Represent QC for Marketing and Business Development. Responsible for 21 lab personnel in two groups: Diagnostic Kits & Enzyme Reagents. Validation, Stability and Technical Support for cytokine ELISA kits. Method transfer and support for Manufacturing. Represent QC for Marketing and Business Development.

    • Events Services
    • 1 - 100 Employee
    • Group Head QC Bioassay
      • 1992 - 1995

      Responsible for 10 laboratory staff performing bioassay and ELISA for IL-2, IL-12, BMP-2, FVIII, FIX, GM-CSF, bulk and drug product. Potency and stability determination for clinical and R&D products. Assay validation, raw material testing, mycoplasma, endotoxin, viral assays, cell banks. Responsible for 10 laboratory staff performing bioassay and ELISA for IL-2, IL-12, BMP-2, FVIII, FIX, GM-CSF, bulk and drug product. Potency and stability determination for clinical and R&D products. Assay validation, raw material testing, mycoplasma, endotoxin, viral assays, cell banks.

    • South Africa
    • Wellness and Fitness Services
    • 1 - 100 Employee
    • Manager QC Bioassay
      • 1983 - 1986

      Responsible for 8 laboratory staff performing bioassays and ELISA for IFN-a, IFN-g, IL-2, TNF, to support manufacturing, stability and clinical drug supply. Validation of ELISA for IL-2 to replace KIT bioassay for potency. Developed ELISA methods for R&D with subsequent technical transfer and validation for QC use. Responsible for 8 laboratory staff performing bioassays and ELISA for IFN-a, IFN-g, IL-2, TNF, to support manufacturing, stability and clinical drug supply. Validation of ELISA for IL-2 to replace KIT bioassay for potency. Developed ELISA methods for R&D with subsequent technical transfer and validation for QC use.

    • Product Development Scientist
      • 1981 - 1983

Education

  • University of New Hampshire
    Doctor of Philosophy (PhD), Microbiology and Immunology
  • University of New Hampshire
    Master of Science (MS), Biochemistry

Community

You need to have a working account to view this content. Click here to join now